(Q45157244)

10 December 2017

Is antioxidant use protective of cognitive function in the community-dwelling elderly? (English)

1 reference

10 December 2017

6

Gerda G Fillenbaum

1 reference

10 December 2017

Shelly L Gray

1

1 reference

10 December 2017

Joseph T Hanlon

2

1 reference

10 December 2017

Lawrence R Landerman

3

1 reference

10 December 2017

Margaret Artz

4

1 reference

10 December 2017

Kenneth E Schmader

5

1 reference

10 December 2017

1 September 2003

1 reference

American Journal of Geriatric Pharmacotherapy

10 December 2017

1 reference

10 December 2017

1

1 reference

10 December 2017

1

1 reference

10 December 2017

3-10

1 reference

Oxidative stress and Alzheimer disease

10 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

High doses of vitamin E in the treatment of disorders of the central nervous system in the aged

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Current status of antioxidant therapy for Alzheimer's Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Use of antioxidant supplements and its association with cognitive function in a rural elderly cohort: the MoVIES Project. Monongahela Valley Independent Elders Survey.

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Association of vitamin E and C supplement use with cognitive function and dementia in elderly men.

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Cohort study of vitamin C intake and cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Vitamin E and cognitive decline in older persons

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Dietary intake of antioxidants and risk of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Epidemiology of over-the-counter drug use in community dwelling elderly: United States perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

The Association of Age and Depression Among the Elderly: An Epidemiologic Exploration

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Drug-use patterns among black and nonblack community-dwelling elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

A Short Portable Mental Status Questionnaire for the Assessment of Organic Brain Deficit in Elderly Patients†

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Sensitivity and specificity of standardized screens of cognitive impairment and dementia among elderly black and white community residents.

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

The relationship of APOE genotype to cognitive functioning in older African-American and Caucasian community residents.

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Relation of smoking and low-to-moderate alcohol consumption to change in cognitive function: a longitudinal study in a defined community of older persons.

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Cognitive impairment: dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Association of education with incidence of cognitive impairment in three established populations for epidemiologic studies of the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Epidemiologic Considerations in Studies of Cognitive Function in the Elderly: Methodology and Nondementing Acquired Dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

A Guttman health scale for the aged

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Screening the elderly. A brief instrumental activities of daily living measure.

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Multidimensionality in instrumental and basic activities of daily living.

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Relation of prescription nonsteroidal antiinflammatory drug use to cognitive function among community-dwelling elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Benzodiazepine use and cognitive function among community-dwelling elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Is geographic variation in hip fracture rates related to current or former region of residence?

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Postmenopausal estrogen and prevention bias

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Coronary heart disease and estrogen replacement therapy. Can compliance bias explain the results of observational studies?

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Comparison of two brief tests of organic brain impairment, the MSQ and the short portable MSQ.

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

Vitamin E and Alzheimer disease: the basis for additional clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1543-5946%2803%2980011-9

7 January 2021

10.1016/S1543-5946(03)80011-9

Identifiers

DOI

1 reference

10 December 2017

1 reference